MX2022011695A - Compuestos para dispositivos opticamente activos. - Google Patents

Compuestos para dispositivos opticamente activos.

Info

Publication number
MX2022011695A
MX2022011695A MX2022011695A MX2022011695A MX2022011695A MX 2022011695 A MX2022011695 A MX 2022011695A MX 2022011695 A MX2022011695 A MX 2022011695A MX 2022011695 A MX2022011695 A MX 2022011695A MX 2022011695 A MX2022011695 A MX 2022011695A
Authority
MX
Mexico
Prior art keywords
compounds
optically active
active devices
ophthalmic devices
novel compounds
Prior art date
Application number
MX2022011695A
Other languages
English (en)
Inventor
Lars Dobelmann-Mara
Stefan Riedmueller
Martin Schraub
Original Assignee
Johnson & Johnson Surgical Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Surgical Vision Inc filed Critical Johnson & Johnson Surgical Vision Inc
Publication of MX2022011695A publication Critical patent/MX2022011695A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/62—Monocarboxylic acids having ten or more carbon atoms; Derivatives thereof
    • C08F20/68—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invención se refiere a nuevos compuestos, particularmente a compuestos que comprenden una unidad fotoactiva, estos nuevos compuestos que son particularmente adecuados para composiciones y dispositivos oftálmicos así como a composiciones y dispositivos oftálmicos que comprenden estos compuestos.
MX2022011695A 2017-02-15 2019-08-12 Compuestos para dispositivos opticamente activos. MX2022011695A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17156326.5A EP3363786A1 (en) 2017-02-15 2017-02-15 Compounds for optically active devices

Publications (1)

Publication Number Publication Date
MX2022011695A true MX2022011695A (es) 2022-10-07

Family

ID=58212899

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019009605A MX2019009605A (es) 2017-02-15 2018-02-14 Compuestos para dispositivos opticamente activos.
MX2022011695A MX2022011695A (es) 2017-02-15 2019-08-12 Compuestos para dispositivos opticamente activos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2019009605A MX2019009605A (es) 2017-02-15 2018-02-14 Compuestos para dispositivos opticamente activos.

Country Status (13)

Country Link
US (1) US11753387B2 (es)
EP (3) EP3363786A1 (es)
JP (2) JP7150736B2 (es)
CN (1) CN110300744B (es)
AU (1) AU2018222562C1 (es)
BR (1) BR112019016724A2 (es)
CA (1) CA3053435A1 (es)
ES (1) ES2885148T3 (es)
HU (1) HUE055412T2 (es)
MX (2) MX2019009605A (es)
PL (1) PL3583092T3 (es)
PT (1) PT3583092T (es)
WO (1) WO2018149856A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3133065A1 (en) 2015-08-21 2017-02-22 Merck Patent GmbH Compounds for optically active devices
EP3363787A1 (en) * 2017-02-15 2018-08-22 Merck Patent GmbH Hydrophobic compounds for optically active devices
EP3363793A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Hydrophobic compounds for optically active devices
EP3363786A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Compounds for optically active devices
US20230084690A1 (en) 2019-04-18 2023-03-16 Merck Patent Gmbh Compounds for optically active devices
KR20220002422A (ko) 2019-04-26 2022-01-06 메르크 파텐트 게엠베하 시스템 및 방법
US20230203214A1 (en) 2020-05-20 2023-06-29 Merck Patent Gmbh Azacoumarin and azathiocoumarin derivatives for use in optically active devices
JP2023534254A (ja) 2020-07-15 2023-08-08 エイエムオー・アイルランド 光活性装置
EP4015512A1 (en) 2020-12-16 2022-06-22 AMO Ireland Optically active devices
EP4036085A1 (en) 2021-01-27 2022-08-03 AMO Ireland Compounds for optically active ophthalmic devices

Family Cites Families (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3351482A (en) 1961-02-21 1967-11-07 Bayer Ag Synthetic textiles brightened with 3-phenyl-7-hydroxy-coumarin
DE1278385B (de) 1965-03-30 1968-09-26 Bayer Ag Aufhellungsmittel
CH514611A (de) 1968-07-05 1971-10-31 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Derivaten des 2-Oxo-1,2-dihydro-chinolins
DE2162721A1 (de) 1970-12-19 1972-06-22 Dr L Zambeletti SpA, Mailand (Italien) Substituierte Cumarine und Verfahren zu ihrer Herstellung
FR2275461A1 (fr) * 1974-06-18 1976-01-16 Labaz Nouveaux stabilisants des polymeres et copolymeres du chlorure de vinyle
FR2368952A1 (fr) 1976-02-25 1978-05-26 Lipha Nouveaux aminoalcoxy-4 (2 h) pyranone-2,3 substitues-5,6 condenses
US4103256A (en) 1976-05-25 1978-07-25 The United States Of America As Represented By The United States Department Of Energy Azacoumarin dye lasers
FR2358395A2 (fr) * 1976-07-15 1978-02-10 Labaz Nouveaux derives du phenyl-2 indole utiles comme stabilisants des polymeres et copolymeres du chlorure de vinyle
JPS5735850A (en) 1980-08-13 1982-02-26 Japan Synthetic Rubber Co Ltd Photoresist composition
US4349619A (en) 1979-09-19 1982-09-14 Japan Synthetic Rubber Co., Ltd. Photoresist composition
JPS60193955A (ja) 1984-03-13 1985-10-02 Mitsui Toatsu Chem Inc 環式不飽和アミド置換エ−テル化合物及びその製造方法
US4785004A (en) 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
JP2876129B2 (ja) 1988-10-22 1999-03-31 東洋ファルマー株式会社 ７―カルボキシメトキシ―４―フェニルクマリン誘導体とその製法及び用途
DE3921669A1 (de) * 1988-12-23 1990-07-05 Bayer Ag Lichtpolarisierende filme oder folien enthaltend stilbenfarbstoffe
JP2876144B2 (ja) 1990-03-23 1999-03-31 東洋フアルマー株式会社 ３―フェニルクマリン―７―イルオキシ酢酸誘導体とその製法及び用途
US5290892A (en) 1990-11-07 1994-03-01 Nestle S.A. Flexible intraocular lenses made from high refractive index polymers
JP2999841B2 (ja) 1991-04-03 2000-01-17 三井化学株式会社 発光スクリーン用樹脂組成物
US5331073A (en) 1992-11-09 1994-07-19 Allergan, Inc. Polymeric compositions and intraocular lenses made from same
TW263498B (es) 1993-11-10 1995-11-21 Takeda Pharm Industry Co Ltd
DE59507348D1 (de) 1994-09-29 2000-01-05 Rolic Ag Zug Cumarin- und chinolinon-derivate zur herstellung von orientierungsschichten für flüssigkristalle
JPH08337583A (ja) 1995-04-13 1996-12-24 Takeda Chem Ind Ltd 複素環化合物およびその製造法
JPH08301849A (ja) 1995-05-01 1996-11-19 Takeda Chem Ind Ltd ヘテロ環化合物およびその製造法
ES2183953T3 (es) 1995-06-07 2003-04-01 Alcon Lab Inc Materiales mejorados de lentes oftalmicas de alto indice de refraccion.
TW349948B (en) 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
JP3275681B2 (ja) 1995-12-26 2002-04-15 大平洋金属株式会社 高純度酸化スカンジュウムの製造法
AU4694999A (en) 1998-08-06 2000-02-28 Warner-Lambert Company Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
US6331562B1 (en) 1998-12-30 2001-12-18 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
US8247511B2 (en) 1999-04-12 2012-08-21 Advanced Vision Science, Inc. Water plasticized high refractive index polymer for ophthalmic applications
US6143766A (en) 1999-04-16 2000-11-07 Warner-Lambert Company Benzopyranone and quinolone inhibitors of ras farnesyl transferase
EP1210381A1 (en) 1999-09-07 2002-06-05 Alcon Universal, Ltd. Ophthalmic and otorhinolaryngological device materials
DE19955836C1 (de) 1999-11-19 2001-05-17 Norbert Hampp Ophthalmologisches Implantat
US9370446B2 (en) 2001-11-07 2016-06-21 Gholam A. Peyman Method of altering the refractive properties of an eye
DE60305545T2 (de) 2002-03-04 2006-11-02 Fuji Photo Film Co., Ltd., Minami-Ashigara Polymerisierbare Flüssigkristallverbindung, Flüssigkristallpolymer und deren Anwendungen
US20050244718A1 (en) 2002-07-01 2005-11-03 Eike Poetsch Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
DE10238725A1 (de) 2002-08-23 2004-03-04 Bayer Cropscience Ag Substituierte Heterocyclypyrimidine
JP2004203751A (ja) 2002-12-24 2004-07-22 Pfizer Inc 置換６，６−ヘテロ二環式誘導体
EP1624900A4 (en) 2003-05-20 2007-05-02 Univ California METHOD OF BINDING AGENTS AT BETA AMYLOID PLAQUE
US20050054586A1 (en) 2003-06-30 2005-03-10 Bartels Stephen P. Treatment of ophthalmic disorders
BRPI0414386A (pt) 2003-09-15 2006-11-21 Signal Pharm Llc composto, métodos para fabricação do mesmo, para tratamento ou prevenção de uma doença, para ativação da função de er em uma célula óssea, para inibição de função de er em uma célula, para inibição da expressão de il-6, para inibição do crescimento de uma célula neoplásica expressando er, para prevenção de espermatogenese, para prevenção de um efeito reprodutivo adverso associados com exposição a uma falta de equilìbrio hormonal natural ou quìmica ambiental, e, composição
US7049309B2 (en) 2003-10-14 2006-05-23 Bristol-Myers Squibb Company 3-Thia-4-arylquinolin-2-one potassium channel modulators
CN1310899C (zh) 2003-11-11 2007-04-18 沈阳化工研究院 具有杀虫、杀菌活性的苯并吡喃酮类化合物及制备与应用
JP2006189604A (ja) 2005-01-06 2006-07-20 Konica Minolta Medical & Graphic Inc 光重合性組成物、感光性平版印刷版材料および平版印刷版の製造方法
EP1846397A1 (en) 2005-01-21 2007-10-24 Janssen Pharmaceutica N.V. Novel heterocyclic benzoy[c]chromene derivatives useful as modulators of the estrogen receptors
DE102005045540A1 (de) 2005-09-23 2007-03-29 Hampp, Norbert, Prof. Dr. Intraokularlinse
EP1958945B1 (en) 2005-12-08 2014-11-12 JNC Corporation Compound having hydrocoumarin skeleton, liquid crystal composition and liquid crystal display element
TW200735862A (en) 2006-01-06 2007-10-01 Abgenomics Corp Prostaglandin reductase inhibitors
JP2007308402A (ja) 2006-05-17 2007-11-29 Sumitomo Chemical Co Ltd シンナモイル化合物及びその用途
JP2007308441A (ja) 2006-05-22 2007-11-29 Sumitomo Chemical Co Ltd 含複素環化合物及びその用途
US7789910B2 (en) 2006-06-28 2010-09-07 Bausch & Lomb Incorporated Optical material and method for modifying the refractive index
US20080004610A1 (en) 2006-06-30 2008-01-03 David Miller System for calculating IOL power
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
WO2008096673A1 (ja) 2007-02-06 2008-08-14 Konica Minolta Medical & Graphic, Inc. 感光性平版印刷版材料
WO2009032754A2 (en) 2007-08-31 2009-03-12 Kalypsys, Inc. Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease
DE102007059470B3 (de) * 2007-12-11 2009-05-20 *Acri.Tec Gmbh Ophthalmologische Zusammensetzung und deren Verwendung
US20110028667A1 (en) 2007-12-11 2011-02-03 Helmut Ritter Copolymer and Ophthalmological Composition
EP2237784A1 (en) 2008-01-11 2010-10-13 The Regents of the University of California Activators of executioner procaspases 3, 6 and 7
JPWO2009139462A1 (ja) 2008-05-16 2011-09-22 日本電気株式会社 有機シリコン化合物およびシリカ系微粒子形成用材料
JP5402266B2 (ja) 2008-06-10 2014-01-29 三菱化学株式会社 光反応性組成物、光学材料、ホログラム記録層形成用組成物、ホログラム記録材料およびホログラム記録媒体
WO2010049044A1 (de) 2008-10-29 2010-05-06 Merck Patent Gmbh Flüssigkristallanzeige
US20110201501A1 (en) 2008-10-29 2011-08-18 Basf Se Substituted Pyridines Having a Herbicidal Effect
DE102008063742A1 (de) 2008-12-18 2010-07-01 *Acri.Tec Gmbh Farbstoff, ophthalmologische Zusammensetzung und ophthalmologische Linse
ES2343347B2 (es) 2009-01-27 2011-12-07 Universidade De Santiago De Compostela Uso de derivados de 3-fenilcumarinas 6-sustituidas y preparacion de nuevos derivados.
US8292952B2 (en) 2009-03-04 2012-10-23 Aaren Scientific Inc. System for forming and modifying lenses and lenses formed thereby
JP5463963B2 (ja) 2009-03-09 2014-04-09 信越化学工業株式会社 ポジ型レジスト材料並びにこれを用いたパターン形成方法
JP5263072B2 (ja) 2009-08-21 2013-08-14 セイコーエプソン株式会社 印刷装置、印刷システム、印刷装置の制御方法およびプログラム
WO2011057942A1 (en) 2009-11-12 2011-05-19 Basf Se Insecticidal methods using pyridine compounds
DE102011009691A1 (de) 2010-02-09 2011-08-11 Merck Patent GmbH, 64293 Flüssigkristallines Medium
JP2013522339A (ja) 2010-03-23 2013-06-13 ビーエーエスエフ ソシエタス・ヨーロピア 除草作用を有する置換されたピリジン
WO2011123484A2 (en) 2010-03-31 2011-10-06 Novartis Ag Adjustable intraocular lens system
DE102011105930A1 (de) 2010-07-21 2012-01-26 Merck Patent Gmbh Polymerisierbare Mischungen und ihre Verwendung in Flüssigkristallanzeigen
JP2012124297A (ja) 2010-12-08 2012-06-28 Konica Minolta Holdings Inc 有機光電変換素子および太陽電池
WO2012097858A1 (en) 2011-01-20 2012-07-26 Merck Patent Gmbh Polymerisable compounds and the use thereof in liquid-crystal displays
CN102206214B (zh) 2011-04-07 2014-03-12 华中科技大学 苯并吡喃酮类衍生物及其应用
WO2012150550A1 (en) 2011-05-04 2012-11-08 Basf Se Novel pesticidal amino pyranone compounds
CN102532015B (zh) 2012-01-18 2013-10-23 云南大学 香豆素及其类似物的固相合成方法
BR112014021531B1 (pt) 2012-03-01 2022-10-04 Ptc Therapeutics, Inc. Composto, composição farmacêutica e usos dos mesmos
JP6472755B2 (ja) 2012-12-12 2019-02-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 液晶媒体
US10386653B2 (en) 2012-12-21 2019-08-20 Johnson & Johnson Vision Care, Inc. Variable optic ophthalmic device including liquid crystal elements
US10441676B2 (en) 2013-01-15 2019-10-15 Medicem Institute s.r.o. Light-adjustable hydrogel and bioanalogic intraocular lens
EP2837671B1 (de) 2013-08-16 2017-10-25 Merck Patent GmbH Flüssigkristallines Medium
US9541772B2 (en) 2013-09-17 2017-01-10 Johnson & Johnson Vision Care, Inc. Methods and apparatus for ophthalmic devices including cycloidally oriented liquid crystal layers
SG10201405242WA (en) 2013-09-17 2015-04-29 Johnson & Johnson Vision Care Variable optic ophthalmic device including liquid crystal elements
KR101558733B1 (ko) * 2014-02-11 2015-10-15 한림대학교 산학협력단 모라신 n 합성방법
TWI701249B (zh) 2015-03-13 2020-08-11 德商４Ｓｃ製藥公司 Ｋv１.３抑制劑及其醫學應用
CN107743485B (zh) * 2015-06-12 2021-10-22 光学转变公司 取向化合物
EP3133066A1 (en) 2015-08-21 2017-02-22 Merck Patent GmbH Hydrophilic compounds for optically active devices
EP3133067A1 (en) 2015-08-21 2017-02-22 Merck Patent GmbH Compounds for optically active devices
EP3133065A1 (en) 2015-08-21 2017-02-22 Merck Patent GmbH Compounds for optically active devices
CN106810559A (zh) 2015-11-27 2017-06-09 成都融科博海科技有限公司 成纤维细胞生长因子受体选择性抑制剂及其应用
CN105753837B (zh) 2016-03-18 2018-04-24 石家庄诚志永华显示材料有限公司 含有苯并噻吩的可聚合化合物
WO2017221068A1 (en) 2016-06-23 2017-12-28 Medicem Ophthalmic (Cy) Limited Light-adjustable hydrogel and bioanalogic intraocular lens
CN106810560B (zh) 2016-12-23 2019-03-01 天津科技大学 一种8-氮杂香豆素的合成方法及其在抗肿瘤药物中的应用
US10932901B2 (en) 2017-02-10 2021-03-02 University Of Rochester Vision correction with laser refractive index changes
EP3363793A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Hydrophobic compounds for optically active devices
EP3363794A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Bis-compounds for optically active devices
EP3363787A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Hydrophobic compounds for optically active devices
EP3363786A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Compounds for optically active devices
EP3363792A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Compounds containing si atoms for optically active devices
EP3363791A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Hydrophilic compounds for optically active devices
WO2018171688A1 (en) 2017-03-22 2018-09-27 Taipei Medical University Atf3 induction compounds
EP3502147A1 (de) 2017-12-22 2019-06-26 Merck Patent GmbH Zusammensetzung für ophthalmologische produkte

Also Published As

Publication number Publication date
CA3053435A1 (en) 2018-08-23
JP2020507603A (ja) 2020-03-12
WO2018149856A1 (en) 2018-08-23
EP3889135B1 (en) 2023-08-02
JP2022185026A (ja) 2022-12-13
EP3583092A1 (en) 2019-12-25
US20190389827A1 (en) 2019-12-26
AU2018222562C1 (en) 2022-08-04
PL3583092T3 (pl) 2021-11-08
JP7150736B2 (ja) 2022-10-11
EP3583092B1 (en) 2021-05-26
US11753387B2 (en) 2023-09-12
AU2018222562A1 (en) 2019-10-03
BR112019016724A2 (pt) 2020-04-07
CN110300744A (zh) 2019-10-01
AU2018222562B2 (en) 2022-01-20
PT3583092T (pt) 2021-08-30
EP3889135A1 (en) 2021-10-06
MX2019009605A (es) 2019-11-08
HUE055412T2 (hu) 2021-11-29
ES2885148T3 (es) 2021-12-13
CN110300744B (zh) 2023-09-15
EP3363786A1 (en) 2018-08-22

Similar Documents

Publication Publication Date Title
MX2022011695A (es) Compuestos para dispositivos opticamente activos.
MX2019009606A (es) Bis-compuestos para dispositivos opticamente activos.
MX2018001793A (es) Compuestos para dispositivos opticamente activos.
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
DK3577110T3 (da) 8-oxetan-3-yl-3,8-diazabicyclo[3.2.1]octan-3-yl-substituerede forbindelser som hiv-inhibitorer
AU2018258581A8 (en) RAF-degrading conjugate compounds
AU2014375265A1 (en) Novel pyrazolyl-heteroarylamides as pesticides
MX2017002969A (es) Composiciones detergentes que contienen un surfactante ramificado.
MX2017004780A (es) Nuevos peptidos inmunogenos.
AU2015208932A8 (en) (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase I inhibitors
MY164536A (en) Syringe
PH12015502546B1 (en) 3-(4-isobutyl-2-methylphenyl) propanal as perfume ingredient
EA201992177A1 (ru) Композиции на основе нирапариба
EA201790064A1 (ru) Пестицидные композиции
MX2017000827A (es) Composiciones de azucar para la formacion de comprimidos por compresion directa.
MX2018015125A (es) Nuevos compuestos antibacterianos.
AU2015339087B2 (en) Trifluoromethyl alcohols as modulators of RORyt
TR201910057T4 (tr) Kauçuk bi̇leşi̇mleri̇
PH12016501252A1 (en) Novel tetrahydropyridopyrimidine compound or salt thereof
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
GB2568181A (en) Wheat
MX2019010950A (es) Composicion de fotosensibilizador que contiene fenalen-1-ona, compuesto de fenalen-1-ona, asi como su uso.
EA202090732A1 (ru) Составы для трансдермального введения
PH12021550102A1 (en) Cardiosafe antidiabetic therapy
WO2016190501A8 (ko) 유기 광전자 소자용 화합물, 유기 광전자 소자용 조성물, 및 이를 포함하는 유기 광전자 소자 및 표시장치